Search - tctmd.com

Displaying 121 - 140 of 368

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

October 12, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Michael O'Riordan

September 23, 2021

News Daily News

Mechanical Stroke Thrombectomy May Reduce Death: Meta-analysis

Todd Neale

September 14, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News CV Team Pro

Keith Tottenham

L.A. McKeown

June 23, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

News Daily News

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

L.A. McKeown

April 26, 2021

News Daily News

FDA: Class I Recall of Precise PRO Rx Carotid Stent System

Caitlin E. Cox

April 23, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News ISC 2021

Adjustable Stent Retriever Performs Well in IDE Trial

Todd Neale

March 24, 2021

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Daily News

No Paclitaxel Death Signal in VA Data Out to 3 Years

L.A. McKeown

February 11, 2021

News Daily News

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

Caitlin E. Cox

February 11, 2021

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

L.A. McKeown

January 12, 2021

News Opinion Editor's Corner

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

Shelley Wood

December 29, 2020

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

Advertisement

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Mechanical Stroke Thrombectomy May Reduce Death: Meta-analysis

September 2021 News Roundup

Keith Tottenham

June 2021 News Roundup

TCTMD’s Top 10 Most Popular Stories for May 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

FDA: Class I Recall of Precise PRO Rx Carotid Stent System

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Adjustable Stent Retriever Performs Well in IDE Trial

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

No Paclitaxel Death Signal in VA Data Out to 3 Years

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content